BMJ Connections Oncology

BMJ Publishing Group

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

BMJ Connections Oncology is an open-access journal published by BMJ Publishing Group in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,390 GBP. Declared review time at DOAJ: 19 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
BMJ Publishing Group
ISSN
3049-5784
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,390 GBP
Articles in DOAJ
0
Declared review time
19 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2026-03-26
Indexing
DOAJ
APC
2,390 GBP
Declared review time (DOAJ)
19 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

0

Average review time (journal-declared via DOAJ)

19weeks

Works in OpenAlex

15

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

1

i10-index

0

From OpenAlex open data (CC0).

Editorial & policy9
Added to DOAJ
2026-03-26
Declared plagiarism screening
Declared
Other fees beyond APC
No
Editorial board
Official page ↗
Open references deposited at Crossref
88%
ORCID iDs in current deposits
88%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9919251316806676
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Economic and Financial Impacts of Cancer
  • Economic and Financial Impacts of Cancer
  • Cancer survivorship and care
  • Cancer survivorship and care
  • Medication Adherence and Compliance
  • Statistical Methods in Clinical Trials
  • Cancer Genomics and Diagnostics
  • Frailty in Older Adults
Show all subjects (50)
  • Global Cancer Incidence and Screening
  • Frailty in Older Adults
  • Cancer Genomics and Diagnostics
  • Global Cancer Incidence and Screening
  • Medication Adherence and Compliance
  • Statistical Methods in Clinical Trials
  • Salivary Gland Tumors Diagnosis and Treatment
  • COVID-19 and healthcare impacts
  • CAR-T cell therapy research
  • Salivary Gland Disorders and Functions
  • Patient-Provider Communication in Healthcare
  • BRCA gene mutations in cancer
  • Health Systems, Economic Evaluations, Quality of Life
  • Immunotherapy and Immune Responses
  • Advanced Causal Inference Techniques
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Salivary Gland Disorders and Functions
  • CAR-T cell therapy research
  • COVID-19 and healthcare impacts
  • Salivary Gland Tumors Diagnosis and Treatment
  • Ethics in Clinical Research
  • Colorectal Cancer Screening and Detection
  • Sexual function and dysfunction studies
  • Pelvic floor disorders treatments
  • Nutrition and Health in Aging
  • Head and Neck Cancer Studies
  • Palliative Care and End-of-Life Issues
  • Cancer Immunotherapy and Biomarkers
  • Patient-Provider Communication in Healthcare
  • BRCA gene mutations in cancer
  • Health Systems, Economic Evaluations, Quality of Life
  • Immunotherapy and Immune Responses
  • Advanced Causal Inference Techniques
  • Sexual function and dysfunction studies
  • Colorectal Cancer Screening and Detection
  • Ethics in Clinical Research
  • Cancer Immunotherapy and Biomarkers
  • Palliative Care and End-of-Life Issues
  • Head and Neck Cancer Studies
  • Nutrition and Health in Aging
  • Pelvic floor disorders treatments
  • Chemotherapy-induced cardiotoxicity and mitigation

Keywords (DOAJ)

  • oncology
  • cancer
  • cancer research

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: